OTECH’s medical grade PVC compounds are the emerging choice in the regulated market for formulations engineered for clear tubing, injection molded parts and film applications. All of OTECH’s medical grade compounds are designed and produced for superior clarity, thermal stability and processability in its state-of-the-art segregated medical grade compounding facility.
Through newly engineered plant automation, OTECH delivers superior lot-to-lot traceability and consistency, and product purity through raw material and finished goods isolation in a fully controlled environment. We offer a full array of EO, Gamma stable compounds for extrusion and injection molding applications.
OTECH’s products are designed with a one-size-fits-all approach through cross certifications for compliance to USP Class VI, FDA 21CFR10, CA Prop 65, REACH/RoHS, NSF 51 & 61, and UL. All OTECH products are DEHP and phthalate free.
Formulation choices that minimize patient exposure risk.
Formulating medical-grade PVC and TPE compounds with minimal extractables and leachables (E&L) primarily involves careful material selection and ensuring a tightly controlled manufacturing process. The goal is to use highly pure ingredients that are less likely to migrate from the polymer matrix into the patient or drug product.
For flexible PVC, use of low migration plasticizers such as DOTP or TOTM can minimize the risk of migration. TPEs inherently do not require plasticizers to achieve flexibility, eliminating this common source of leachables.
Ensure all raw materials are listed as FDA food-grade compliant ingredients and certified to ISO 10993 standards for biocompatibility. Limit the use of unnecessary additives, focusing on essential components that have a proven low-E&L profile.
ETO, gamma, e-beam, and autoclave compatibility by resin family.
For EtO sterilization, both PVC and TPEs are generally very compatible, though EtO requires aeration for residuals.
Gamma/E-beam requires specific stabilizers for PVC; TPEs (HSBCs) offer inherent stability but can still discolor, needing formulation care.
For autoclave sterilization, TPEs often outperform PVC here; PVC needs heat-stabilized grades. Silicone is a benchmark but TPEs offer cost-effectiveness.
The selection and auditing of medical-grade compounders for materials such as Polyvinyl Chloride (PVC) and Thermoplastic Elastomers (TPE) is a critical component of medical device manufacturing. This process necessitates a mandatory, robust Quality Management System (QMS) that is not merely compliant, but proactive in ensuring the safety, efficacy, and consistent quality of the materials supplied.
A comprehensive QMS for these specialized compounders must be meticulously documented and rigorously enforced, drawing its primary guidance from two international and federal benchmarks:
Blood set tubing with low extractables profiles.
For blood set tubing requiring low extractable profiles, both medical-grade PVC and TPE compounds are viable options, with TPE generally offering superior purity profiles and DEHP-free PVC being a widely used, cost-effective alternative.
TPEs are generally favored for their high purity and inherently low levels of extractable compounds, making them a material of choice for sensitive medical and biopharma applications.
Medical-grade PVC is a workhorse in the medical market due to its excellent combination of price, durability, chemical resistance, and flexibility. Modern formulations often use alternative plasticizers to achieve a low extractable profile.
Autoclavable device components that resist embrittlement.
For autoclavable medical device components, TPE compounds are generally a better choice for resisting embrittlement compared to most PVC formulations, though some specialized PVC compounds are available. The key is to select medical-grade materials specifically engineered for repeated steam sterilization.
Medical-grade TPEs are often designed to be highly resistant to heat, chemicals, and environmental stress, allowing them to withstand autoclaving without degrading or losing functionality. They are a popular alternative to traditional materials like silicone or PVC due to their flexibility, durability, and processing efficiency.
While many standard PVC formulations can deform or crack after a few autoclave cycles, specific medical-grade PVC compounds designed to resist hardening and discoloration are available. The main advantage of PVC is its versatility, chemical resistance, and cost-effectiveness.
Full batch genealogy for Class II submissions.
The term “full batch genealogy” refers to complete, end-to-end traceability of all components, sub-assemblies, and processes associated with a specific manufactured batch or lot of a medical device, from raw materials to the finished product.
For Class II medical devices, the FDA requires manufacturers to maintain detailed records that demonstrate consistent production and control according to quality standards (21 CFR Part 820, Quality System Regulation). This is typically achieved through a robust Device History Record (DHR) system, which essentially serves as the batch record.
TOTM, DOTP, and citrate options for safer flexibility.
TOTM (trioctyl trimellitate), DOTP (dioctyl terephthalate), and citrate-based plasticizers are commonly used as non-phthalate alternatives in medical PVC compounds due to health and environmental concerns surrounding traditional plasticizers like DEHP. Each offers a different balance of properties for specific medical applications.
TOTM is a high molecular weight, branched plasticizer valued for applications requiring permanence and resistance to extraction. DOTP (also known as DEHT) is a general-purpose, cost-effective, non-phthalate plasticizer that is widely used as a direct replacement for DEHP in many applications. DOTP (also known as DEHT) is a general-purpose, cost-effective, non-phthalate plasticizer that is widely used as a direct replacement for DEHP in many applications.
Balancing gel count, haze, and bend performance in tubing.
Balancing gel count, haze, and bend performance in medical tubing requires an integrated approach focusing on material selection, precise extrusion process control, and optimized equipment design. Adjusting one property often impacts the others, making a holistic strategy essential for meeting performance and quality standards.
The key to balancing these properties is a collaborative approach involving material suppliers and extrusion engineers early in the design phase. The trade-offs are often inherent to polymer behavior:
Increasing strength (often related to higher crystallinity or specific material choices) can reduce flexibility (bend performance).
Maximizing clarity (minimizing haze and gels) requires precise material processing and filtration, which may add cost or affect other process parameters like throughput.
Ultimately, extensive testing under actual operational conditions is necessary to validate that the chosen material and process combination meet all performance, safety, and regulatory requirements.
Stabilizer packages that protect optics and mechanics post-cycle.
Medical-grade PVC and TPE compounds that retain their color and mechanical properties after both gamma and ethylene oxide (EtO) sterilization are available, often requiring specialized formulations with specific additives.
Standard PVC formulations tend to darken or yellow significantly after gamma irradiation due to oxidation and the formation of conjugated double bonds, with the color change potentially continuing over time (post-sterilization shelf life). However, specific medical-grade PVC compounds are formulated with special radiation-stabilizing additives to minimize this effect.
TPEs generally show good property retention and minimal loss over time after sterilization. EtO sterilization has minimal effects on the color and mechanical properties of TPEs due to its low-temperature, gentle nature. Certain TPE formulations are specifically designed for radiation stability as well.
IV bags using citrate-plasticized PVC.
Medical-grade PVC compounds for IV bags are widely available with alternative, non-phthalate plasticizers, particularly citrate-based plasticizers like acetyl tributyl citrate (ATBC) and n-butyryl tri-n-hexyl citrate (B-6). These are considered safe, effective alternatives to the traditional DEHP plasticizer and meet global regulatory and biocompatibility requirements.Citrate esters are an excellent alternative to phthalate plasticizers for medical PVC applications, offering a clean toxicological profile and robust performance.
Clear pump tubing that resists kinking in peristaltic use.
For clear, kink-resistant PVC medical tubing suitable for peristaltic pump use, you should look for formulations that are explicitly designed for this application and are often described as high molecular weight or phthalate-free, as these properties improve flexibility and durability. Kink resistance in peristaltic pump tubing is a balance of material flexibility (durometer) and design.Specific PVC compounds (e.g., high molecular weight, non-phthalate) are formulated to enhance flexibility and tear resistance, which directly contributes to better kink resistance in peristaltic use.
ETO-sterilized components with stable transparency.
Both PVC and TPE medical compounds are available in clear formulations that are compatible with EtO (ethylene oxide) sterilization and are designed to maintain stable transparency. Manufacturers produce specific grades of these materials tailored for medical applications requiring high clarity and resistance to various sterilization methods. PVC (polyvinyl chloride) is widely used in the healthcare industry for its versatility, durability, and inherent clarity. Formulations with appropriate plasticizers and stabilizers ensure stable transparency after EtO sterilization. TPEs (thermoplastic elastomers) are popular alternatives to PVC and silicone due to their high purity, flexibility, and processing advantages. Many TPE grades offer excellent transparency and are compatible with EtO and other sterilization methods.
Adhesion to PP and PC for multi-material assemblies.
Formulating TPE compounds to bond with polypropylene (PP) and polycarbonate (PC) for medical use requires selecting specific, adhesion-optimized TPE grades designed for chemical compatibility with the target substrate. This process is typically achieved through overmolding (two-shot or insert molding) rather than traditional compounding. Standard TPEs that bond well with PP will not necessarily bond with PC, as they have different solubility parameters. You must use TPE grades specifically engineered for the target substrate.
The most efficient manufacturing process is often two-shot injection molding, where the rigid substrate is molded in the first shot and the TPE is overmolded in the second, all within the same machine. This ensures the substrate is still warm, which facilitates better molecular diffusion and a stronger bond.
Sensory and VOC controls for patient comfort and safety.
Formulating TPE (thermoplastic elastomer) medical compounds for specific sensory profiles and low volatile organic compound (VOC) emissions requires careful material selection and processing techniques to ensure biocompatibility and meet stringent regulatory standards (e.g., ISO 10993, USP Class VI).
Utilize TPEs made from high-purity, FDA-compliant raw materials, such as specific styrenic block copolymers (SBCs, TPE-S). The polymer structure, with its balance of hard (crystalline) and soft (amorphous) segments, determines many physical properties.
The manufacturing process is critical. Using appropriate processing temperatures and ensuring complete cooling before packaging helps reduce residual odors in the final pellets and products.
Study endpoints and pathways for biological evaluation.
Developing medical-grade Thermoplastic Elastomer (TPE) and Polyvinyl Chloride (PVC) compounds specifically for applications requiring hemocompatibility—the ability of a material to not cause adverse reactions when in contact with blood—is a highly complex and critical process. This development necessitates a multi-faceted approach encompassing meticulous material selection, rigorous and comprehensive laboratory testing, and adherence to a robust, structured risk management framework.
The cornerstone of this process is the adherence to the International Organization for Standardization (ISO) 10993 series of standards, which provides the globally recognized biological evaluation framework for medical devices. Of paramount importance is ISO 10993-4, Biological evaluation of medical devices – Part 4: Selection of tests for interactions with blood. This standard dictates the specific tests required to assess a material’s impact on blood components, ensuring that the finished TPE or PVC compound minimizes the risks of:
For TPE compounds, this often involves careful selection of base polymers (e.g., polyurethanes, styrenic block copolymers, or copolyesters) and plasticizers (when needed) that possess inherent non-thrombogenic properties. For PVC compounds, specialized stabilizers and plasticizers must be chosen to ensure safety and prevent leaching of cytotoxic components while maintaining the necessary flexibility and clarity. The entire formulation must undergo sterilization compatibility assessments, as sterilization processes (e.g., EtO, gamma radiation, steam) can alter the material’s surface chemistry and potentially compromise its hemocompatibility.
TPE catheter components overmolded onto PP hubs.
Formulating medical-grade Thermoplastic Elastomers (TPEs) for overmolding onto Polypropylene (PP) hubs involves selecting specific compatible materials and optimizing processing conditions to achieve a strong, permanent bond that meets stringent regulatory requirements.
The key to a successful TPE-to-PP bond is selecting a TPE formulation specifically designed for adhesion to polyolefins, as PP has low surface energy and is naturally difficult to bond with general-purpose TPEs. Adhesion is primarily achieved through a chemical bond (polymer chain diffusion and entanglement) at the interface during the molding process, which is highly dependent on sufficient heat transfer.
Mask seals with low odor for patient comfort.
Formulating medical-grade Thermoplastic Elastomer (TPE) compounds for low-odor mask seals is a highly specialized and multi-faceted process. It necessitates the meticulous selection of ultra-high-purity, biocompatible raw materials, ensuring compliance with stringent regulatory standards such as ISO 10993 and USP Class VI. The core challenge lies in balancing critical mechanical attributes—such as flexibility, resilience, and long-term sealing integrity—with demanding sensory properties, specifically the requirement for a virtually odorless profile. This low-odor characteristic is paramount for patient comfort and compliance, particularly in sensitive applications like continuous positive airway pressure (CPAP) or surgical masks, where prolonged contact with the skin and airways is common.
Achieving this balance requires close collaboration with specialized suppliers who can provide highly controlled and purified ingredients. These components include the base polymer (often a styrenic block copolymer or a polyolefin-based TPE), plasticizers (which must be non-phthalate and low-volatility), stabilizers, and colorants. A key focus is on minimizing the presence of volatile organic compounds (VOCs) and residual processing aids, which are the primary contributors to off-gassing and odor. Sophisticated compounding techniques, such as twin-screw extrusion under controlled temperature and atmospheric conditions, are employed to ensure homogenous mixing while preventing thermal degradation, which can also generate unwanted odors. Furthermore, the final compound must be subjected to rigorous sensory testing protocols to verify its low-odor status before being molded into the final mask seal product.
ISO 10993-validated grips for handheld diagnostics.
For handheld diagnostic devices, the TPE compounds for grips must be medical-grade and specifically formulated to meet the ISO 10993 series of standards for biocompatibility. Key suppliers offer pre-tested, off-the-shelf options as well as custom formulations.
When selecting a TPE, it is crucial to consider the device’s specific use case, including the nature and duration of skin contact (limited, prolonged, or long-term), as this dictates the required level of testing under ISO 10993. Engaging with a material supplier early can streamline the material selection and validation process, ensuring the final product meets all regulatory and performance requirements.
4744 E. Oaknoll Road
Rolling Prairie, IN 46371
Phone: 219-778-8001
Fax: 219-778-8007
"*" indicates required fields